A peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms
Molecular Cell · 2023
DOI: 10.1016/j.molcel.2023.07.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2023. Verfasst von Min Cao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Newcastle University Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. Hauptthemen laut MEDLINE: p38 Mitogen-Activated Protein Kinases, Peroxiredoxins. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, NCI NIH HHS, North West Cancer Research.
Abstract (Originalsprache)
Peroxiredoxins (Prdxs) utilize reversibly oxidized cysteine residues to reduce peroxides and promote H2O2 signal transduction, including H2O2-induced activation of P38 MAPK. Prdxs form H2O2-induced disulfide complexes with many proteins, including multiple kinases involved in P38 MAPK signaling. Here, we show that a genetically encoded fusion between a Prdx and P38 MAPK is sufficient to hyperactivate the kinase in yeast and human cells by a mechanism that does not require the H2O2-sensing cysteine of the Prdx. We demonstrate that a P38-Prdx fusion protein compensates for loss of the yeast scaffold protein Mcs4 and MAP3K activity, driving yeast into mitosis. Based on our findings, we propose that the H2O2-induced formation of Prdx-MAPK disulfide complexes provides an alternative scaffold and signaling platform for MAPKK-MAPK signaling. The demonstration that formation of a complex with a Prdx is sufficient to modify the activity of a kinase has broad implications for peroxide-based signal transduction in eukaryotes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Newcastle University Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
- Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.
- Newcastle University Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
- Newcastle University Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. Electronic address: e.a.veal@ncl.ac.uk.
Förderung
- Biotechnology and Biological Sciences Research Council
- NCI NIH HHS
- North West Cancer Research
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Cao, M., Day, A. M., Galler, M., Latimer, H. R., Byrne, D. P., Foy, T. W., Dwyer, E., Bennett, E., Palmer, J., Morgan, B. A., Eyers, P. A., & Veal, E. A. (2023). A peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms. Molecular Cell. https://doi.org/10.1016/j.molcel.2023.07.018
Vancouver
Cao M, Day AM, Galler M, Latimer HR, Byrne DP, Foy TW, et al. A peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms. Molecular Cell. 2023. doi:10.1016/j.molcel.2023.07.018
BibTeX
@article{Cao2023,
author = {Cao, Min and Day, Alison M and Galler, Martin and Latimer, Heather R and Byrne, Dominic P and Foy, Thomas W and Dwyer, Emilia and Bennett, Elise and Palmer, Jeremy and Morgan, Brian A and Eyers, Patrick A and Veal, Elizabeth A},
title = {A peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms},
journal = {Molecular Cell},
year = {2023},
doi = {10.1016/j.molcel.2023.07.018}
}
EUVIMED